Role of IFN-gamma in immune responses to Candida albicans infections

Frontiers in Bioscience - Landmark

Volumn 19, Issue 8, 2014, Pages 1279-1290

  Gozalbo, Daniel ^a   Maneu, Victoria ^b   Gil, María Luisa ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b UNIVERSITY OF ALICANTE   (Spain)

Author keywords

Candida albicans; Candidiasis; IFN gamma; Infection; Review

Indexed keywords

GAMMA INTERFERON;

CANDIDA ALBICANS; CANDIDIASIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; NATURAL KILLER CELL; PHYSIOLOGY; T LYMPHOCYTE; TH17 CELL;

CANDIDA ALBICANS; CANDIDIASIS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE SYSTEM; INTERFERON-GAMMA; KILLER CELLS, NATURAL; T-LYMPHOCYTES; TH17 CELLS;

EID: 84904566730     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4281     Document Type: Article

References (110)

1. W Hope, P Natarajan and L Goodwin: Invasive fungal infections. Clin Med 13, 507-510 (2013)
2. J Kim and P Sudbery: Candida albicans, a major human fungal pathogen. J Microbiol 49, 171-177 (2011)
3. JC Sardi, L Scorzoni, T Bernardi, AM Fusco-Almeida and MJ Mendes Giannini: Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. J Med Microbiol 62, 10-24 (2013)
4. RA Calderone: Candida and candidiasis. New York: American Society for Microbiology. (2001)
5. MA Pfaller and DJ Diekema: Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 20, 133-163 (2007) (Pubitemid 46167771)
6. L Romani: Immunity to fungal infections. Nat Rev Immunol 11, 275-288 (2011)
7. ML Gil and D Gozalbo: TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae. Microbes Infect 8, 2299-2304 (2006) (Pubitemid 44311598)
8. ML Gil and D Gozalbo: Role of Toll-like receptors in systemic Candida albicans infections. Front Biosci 14, 570-582 (2009)
9. HS Goodridge and DM Underhill: Fungal Recognition by TLR2 and Dectin-1. Handb Exp Pharmacol 183, 87-109 (2008)
10. D Poulain and T Jouault: Candida albicans cell wall glycans, host receptors and responses: elements for a decisive crosstalk. Curr Opin Microbiol 7, 342-349 (2004) (Pubitemid 39091117)
11. T Zelante, C Montagnoli, S Bozza, R Gaziano, S Bellocchio, P Bonifazi, S Moretti, F Fallarino, P Puccetti and L Romani: Receptors and pathways in innate antifungal immunity: the implication for tolerance and immunity to fungi. Adv Exp Med Biol 590, 209-221 (2007)
12. T Kawai and S Akira: The role of patternrecognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11, 373-384 (2010)
13. AP West, AA Koblansky and S Ghosh: Recognition and signaling by toll-like receptors. Annu Rev Cell Dev Biol 22, 409-437 (2006)
14. A Mencacci, E Cenci, G Del Sero, C Fe d'Ostiani, P Mosci, G Trinchieri, L Adorini and L Romani: IL-10 is required for development of protective Th1 responses in IL-12-deficient mice upon Candida albicans infection. J Immunol 161, 6228-6237 (1998) (Pubitemid 28535996)
15. A Mencacci, G Del Sero, E Cenci, CF d'Ostiani, A Bacci, C Montagnoli, M Kopf and L Romani: Endogenous interleukin 4 is required for development of protective CD4+ T helper type 1 cell responses to Candida albicans. J Exp Med 187, 307-317 (1998) (Pubitemid 28080060)
16. C Montagnoli, A Bacci, S Bozza, R Gaziano, P Mosci, AH Sharpe and L Romani: B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 169, 6298-6308 (2002) (Pubitemid 36903477)
17. HR Conti, F Shen, N Nayyar, E Stocum, JN Sun, MJ Lindemann, AW Ho, JH Hai, JJ Yu, JW Jung, SG Filler, P Masso-Welch, M Edgerton and SL Gaffen: Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis. J Exp Med 206, 299-311 (2009)
18. N Hernandez-Santos and SL Gaffen: Th17 cells in immunity to Candida albicans. Cell Host Microbe 11, 425-435 (2012)
19. ID Iliev and DM Underhill: Striking a balance: fungal commensalism versus pathogenesis. Curr Opin Microbiol 16, 366-373 (2013)
20. D Gozalbo, P Roig, E Villamón and ML Gil: Candida and candidiasis: the cell wall as a potential molecular target for antifungal therapy. Curr Drug Targets Infect Disord 4, 117-135 (2004) (Pubitemid 38796418)
21. NA Gow, FL van de Veerdonk, AJ Brown and MG Netea: Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10, 112-122 (2011)
22. EF Wheelock: Interferon-like virus-inhibitor induced in human leukocytes by phytohemagglutinin. Science 149, 310-311 (1965)
23. U Boehm, T Klamp, M Groot and JC Howard: Cellular responses to interferon-gamma. Annu Rev Immunol 15, 749-795 (1997)
24. S Kearney, C Delgado and LL Lenz: Differential effects of type I and II interferons on myeloid cells and resistance to intracellular bacterial infections. Immunol Res 55, 187-200 (2013)
25. WJ Leonard and JJ O'Shea: Jaks and STATs: biological implications. Annu Rev Immunol 16, 293-322 (1998) (Pubitemid 28183367)
26. SJ Szabo, BM Sullivan, SL Peng and LH Glimcher: Molecular mechanisms regulating Th1 immune responses. Annu Rev Immunol 21, 713-758 (2003) (Pubitemid 37174546)
27. E Balish, RD Wagner, A Vazquez-Torres, C Pierson and T Warner: Candidiasis in interferon-gamma knockout (IFN-gamma-/-) mice. J Infect Dis 178, 478-487 (1998) (Pubitemid 28347932)
28. E Cenci, A Mencacci, G Del Sero, CF d'Ostiani, P Mosci, A Bacci, C Montagnoli, M Kopf and L Romani: IFN-gamma is required for IL-12 responsiveness in mice with Candida albicans infection. J Immunol 161, 3543-3550 (1998)
29. R Kaposzta, P Tree, L Marodi and S Gordon: Characteristics of invasive candidiasis in gamma interferon- and interleukin-4-deficient mice: role of macrophages in host defense against Candida albicans. Infect Immun 66, 1708-1717 (1998) (Pubitemid 128471538)
30. BJ Kullberg, JW van 't Wout, C Hoogstraten and R van Furth: Recombinant interferon-gamma enhances resistance to acute disseminated Candida albicans infection in mice. J Infect Dis 168, 436-443 (1993) (Pubitemid 23210623)
31. L Romani, E Cenci, A Mencacci, R Spaccapelo, U Grohmann, P Puccetti and F Bistoni: Gamma interferon modifies CD4+ subset expression in murine candidiasis. Infect Immun 60, 4950-4952 (1992)
32. PG de Carvalho, LA Custodio, I Conchon-Costa, C. G. Andrade, G. F. Quirino, R. S. de Almeida and I. Felipe: Concanavalin-A induces IL-17 production during the course of Candida albicans infection. FEMS Immunol Med Microbiol 64, 273-279 (2012)
33. JY Djeu, DK Blanchard, D Halkias and H Friedman: Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor. J Immunol 137, 2980-2984 (1986) (Pubitemid 17177810)
34. L Marodi, S Schreiber, DC Anderson, RP MacDermott, HM Korchak and RB Johnston, Jr.: Enhancement of macrophage candidacidal activity by interferon-gamma. Increased phagocytosis, killing, and calcium signal mediated by a decreased number of mannose receptors. J Clin Invest 91, 2596-2601 (1993) (Pubitemid 23182514)
35. L Marodi: Deficient interferon-gamma receptormediated signaling in neonatal macrophages. Acta Paediatr Suppl 91, 117-119 (2002) (Pubitemid 35347071)
36. FL van de Veerdonk, TS Plantinga, A Hoischen, SP Smeekens, LA Joosten, C Gilissen, P Arts, DC Rosentul, AJ Carmichael, CA Smits-van der Graaf, BJ Kullberg, JW van der Meer, D Lilic, JA Veltman and MG Netea: STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N Engl J Med 365, 54-61 (2011)
37. M Rouabhia, A Semlali, J Audoy and W Chmielewski: Antagonistic effect of Candida albicans and IFNgamma on E-cadherin expression and production by human primary gingival epithelial cells. Cell Immunol 280, 61-67 (2012)
38. M Donini, E Zenaro, N Tamassia and S Dusi: NADPH oxidase of human dendritic cells: role in Candida albicans killing and regulation by interferons, dectin-1 and CD206. Eur J Immunol 37, 1194-1203 (2007) (Pubitemid 46925304)
39. S Bozza, F Fallarino, L Pitzurra, T Zelante, C Montagnoli, S Bellocchio, P Mosci, C Vacca, P Puccetti and L Romani: A crucial role for tryptophan catabolism at the host/Candida albicans interface. J Immunol 174, 2910-2918 (2005) (Pubitemid 40279709)
40. L Romani and P Puccetti: Protective tolerance to fungi: the role of IL-10 and tryptophan catabolism. Trends Microbiol 14, 183-189 (2006)
41. L Lin, AS Ibrahim, X Xu, JM Farber, V Avanesian, B. Baquir, Y Fu, SW French, JE Edwards, Jr. and B Spellberg: Th1-Th17 cells mediate protective adaptive immunity against Staphylococcus aureus and Candida albicans infection in mice. PLoS Pathog 5, e1000703 (2009)
42. CE Zielinski, F Mele, D Aschenbrenner, D Jarrossay, F Ronchi, M Gattorno, S Monticelli, A Lanzavecchia and F Sallusto: Pathogen-induced human TH17 cells produce IFN-gamma or IL-10 and are regulated by IL-1beta. Nature 484, 514-518 (2012)
43. CS Schmidt, CJ White, AS Ibrahim, SG Filler, Y Fu, MR Yeaman, JE Edwards, Jr. and JP Hennessey, Jr.: NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine 30, 7594-7600 (2012)
44. AS Ibrahim, G Luo, T Gebremariam, H Lee, CS Schmidt, JP Hennessey, Jr., SW French, MR Yeaman, SG Filler and JE Edwards, Jr.: NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response. Vaccine 31, 5549-5556 (2013)
45. K Ranta, K Nieminen, T Saariaho, O Kortekangas-Savolainen, EK Kumpula, J Kosonen, AL. Pasanen and J. Savolainen: Evaluation of fungal extracts to determine immunomodulatory properties. J Investig Allergol Clin Immunol 23, 226-233 (2013)
46. I Becker, N Salaiza, M Aguirre, J Delgado, N Carrillo-Carrasco, LG Kobeh, A Ruiz, R Cervantes, AP Torres, N Cabrera, A. Gonzalez, C Maldonado and A Isibasi: Leishmania lipophosphoglycan (LPG) activates NK cells through toll-like receptor-2. Mol Biochem Parasitol 130, 65-74 (2003) (Pubitemid 37289124)
47. A Chalifour, P. Jeannin, JF Gauchat, A Blaecke, M Malissard, T N'Guyen, N Thieblemont and Y Delneste: Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers alpha-defensin production. Blood 104, 1778-1783 (2004) (Pubitemid 39202287)
48. OM Hart, V Athie-Morales, GM O'Connor and CM Gardiner: TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-gamma production. J Immunol 175, 1636-1642 (2005) (Pubitemid 41023066)
49. V Hornung, S Rothenfusser, S Britsch, A Krug, B Jahrsdorfer, T Giese, S Endres and G Hartmann: Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168, 4531-4537 (2002) (Pubitemid 34441357)
50. J Sawaki, H Tsutsui, N Hayashi, K Yasuda, S Akira, T Tanizawa and K Nakanishi: Type 1 cytokine/chemokine production by mouse NK cells following activation of their TLR/MyD88-mediated pathways. Int Immunol 19, 311-320 (2007) (Pubitemid 46344696)
51. S Sivori, M Falco, M Della Chiesa, S Carlomagno, M Vitale, L Moretta and A Moretta: CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc Natl Acad Sci USA 101, 10116-10121 (2004) (Pubitemid 38891204)
52. M Adib-Conquy, D Scott-Algara, JM Cavaillon and F Souza-Fonseca- Guimaraes: TLR-mediated activation of NK cells and their role in bacterial/viral immune responses in mammals. Immunol Cell Biol 92, 256-252 (2014)
53. G Arancia, A Stringaro, P Crateri, A Torosantucci, C Ramoni, F. Urbani, CM Ausiello and A Cassone: Interaction between human interleukin-2-activated natural killer cells and heat-killed germ tube forms of Candida albicans. Cell Immunol 186, 28-38 (1998) (Pubitemid 28285345)
54. P Tran, R Ahmad, J Xu, A Ahmad and J Menezes: Host's innate immune response to fungal and bacterial agents in vitro: up-regulation of interleukin-15 gene expression resulting in enhanced natural killer cell activity. Immunology 109, 263-270 (2003) (Pubitemid 36683618)
55. I Algarra, E Ortega, MJ Serrano, G Alvarez de Cienfuegos and JJ Gaforio: Suppression of splenic macrophage Candida albicans phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice. FEMS Immunol Med Microbiol 33, 159-163 (2002) (Pubitemid 34756561)
56. J Voigt, K Hunniger, M Bouzani, ID Jacobsen, D. Barz, B Hube, J Loffler and O Kurzai: Human Natural Killer Cells Acting as Phagocytes Against Candida albicans and Mounting an Inflammatory Response That Modulates Neutrophil Antifungal Activity. J Infect Dis 209, 616-626 (2014)
57. C Murciano, E Villamon, JE O'Connor, D Gozalbo and ML Gil: Killed Candida albicans yeasts and hyphae inhibit gamma interferon release by murine natural killer cells. Infect Immun 74, 1403-1406 (2006) (Pubitemid 43185583)
58. MA Degli-Esposti and MJ Smyth: Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5, 112-124 (2005) (Pubitemid 40208901)
59. M Della Chiesa, S Sivori, R Castriconi, E Marcenaro and A Moretta: Pathogen-induced private conversations between natural killer and dendritic cells. Trends Microbiol 13, 128-136 (2005) (Pubitemid 40311895)
60. C Stuehler, N Khanna, S Bozza, T Zelante, S Moretti, M Kruhm, S Lurati, B Conrad, E Worschech, S Stevanovic, S Krappmann, H Einsele, JP Latge, J Loeffler, L Romani and MS Topp: Cross-protective TH1 immunity against Aspergillus fumigatus and Candida albicans. Blood 117, 5881-5891 (2011)
61. L Romani: Immunity to Candida albicans: Th1, Th2 cells and beyond. Curr Opin Microbiol 2, 363-367 (1999) (Pubitemid 29366956)
62. N Haraguchi, Y Ishii, Y Morishima, K Yoh, Y Matsuno, N Kikuchi, T Sakamoto, S Takahashi and N Hizawa: Impairment of host defense against disseminated candidiasis in mice overexpressing GATA-3. Infect Immun 78, 2302-2311 (2010)
63. SJ. Orr and DW McVicar: LAB/NTAL/Lat2: a force to be reckoned with in all leukocytes? J Leukoc Biol 89, 11-19 (2011)
64. SJ Orr, AR Burg, T Chan, L Quigley, GW Jones, JW Ford, D Hodge, C Razzook, J Sarhan, YL Jones, GC Whittaker, KC Boelte, L Lyakh, M Cardone, GM O'Connor, C Tan, H Li, SK Anderson, SA Jones, W Zhang, PR Taylor, G Trinchieri and DW McVicar: LAB/NTAL facilitates fungal/PAMP-induced IL-12 and IFN-gamma production by repressing beta-catenin activation in dendritic cells. PLoS Pathog 9, e1003357 (2013)
65. E Cenci, L Romani, A Vecchiarelli, P Puccetti and F Bistoni: T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice. J Immunol 144, 4333-4339 (1990) (Pubitemid 20187777)
66. L Romani, S Mocci, C Bietta, L Lanfaloni, P Puccetti and F Bistoni: Th1 and Th2 cytokine secretion patterns in murine candidiasis: association of Th1 responses with acquired resistance. Infect Immun 59, 4647-4654 (1991)
67. L Romani, A Mencacci, E Cenci, R Spaccapelo, P Mosci, P Puccetti and F Bistoni: CD4+ subset expression in murine candidiasis. Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance. J Immunol 150, 925-931 (1993) (Pubitemid 23133672)
68. E Villamón, D Gozalbo, P Roig, C Murciano, JE O'Connor, D Fradelizi and ML Gil: Myeloid differentiation factor 88 (MyD88) is required for murine resistance to Candida albicans and is critically involved in Candida - induced production of cytokines. Eur Cytokine Netw 15, 263-271 (2004) (Pubitemid 39389923)
69. S Bellocchio, C Montagnoli, S Bozza, R Gaziano, G Rossi, SS Mambula, A Vecchi, A Mantovani, SM Levitz and L Romani: The contribution of the Toll-like/IL-1 receptor superfamily to innate and adaptive immunity to fungal pathogens in vivo. J Immunol 172, 3059-3069 (2004) (Pubitemid 38263695)
70. MG Netea, NA Gow, LA Joosten, I Verschueren, JW van der Meer and BJ Kullberg: Variable recognition of Candida albicans strains by TLR4 and lectin recognition receptors. Med Mycol 48, 897-903 (2010)
71. E Villamón, D Gozalbo, P Roig, JE O'Connor, ML Ferrandiz, D Fradelizi and ML Gil: Toll-like receptor 2 is dispensable for acquired host immune resistance to Candida albicans in a murine model of disseminated candidiasis. Microbes Infect 6, 542-548 (2004) (Pubitemid 38680595)
72. C Murciano, E Villamón, D Gozalbo, P Roig, JE O'Connor and ML Gil: Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol 44, 149-157 (2006) (Pubitemid 43135542)
73. MG Netea, JW van der Meer and BJ Kullberg: Both TLR2 and TLR4 are involved in the recognition of Candida albicans. Reply to "TLR 2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae" by Gil and Gozalbo, Microbes and Infection 8, 2823-2824 (2006). Microbes Infect 8, 2821-2822 (2006) (Pubitemid 44692548)
74. ML Gil and D Gozalbo: Candida albicans, to be or not to be recognized by TLR4? Response to "Both TLR2 and TLR4 are involved in the recognition of Candida albicans" by M. G. Netea et al. Microb Infect 8, 2823-2824 (2006) (Pubitemid 44692549)
75. P Chiani, C Bromuro and A Torosantucci: Defective induction of interleukin-12 in human monocytes by germtube forms of Candida albicans. Infect Immun 68, 5628-5634 (2000)
76. CF d'Ostiani, G Del Sero, A Bacci, C Montagnoli, A Spreca, A Mencacci, P Ricciardi-Castagnoli and L Romani: Dendritic cells discriminate between yeasts and hyphae of the fungus Candida albicans. Implications for initiation of T helper cell immunity in vitro and in vivo. J Exp Med 191, 1661-1674 (2000)
77. L Liu, K Kang, M Takahara, KD Cooper and MA Ghannoum: Hyphae and yeasts of Candida albicans differentially regulate interleukin-12 production by human blood monocytes: inhibitory role of C. albicans germination. Infect Immun 69, 4695-4697 (2001) (Pubitemid 32574476)
78. L Romani, C Montagnoli, S Bozza, K Perruccio, A Spreca, P Allavena, S Verbeek, RA Calderone, F Bistoni and P Puccetti: The exploitation of distinct recognition receptors in dendritic cells determines the full range of host immune relationships with Candida albicans. Int Immunol 16, 149-161 (2004) (Pubitemid 38054636)
79. A Bacci, C Montagnoli, K Perruccio, S Bozza, R Gaziano, L Pitzurra, A Velardi, C. F d'Ostiani, JE Cutler and L Romani: Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 168, 2904-2913 (2002) (Pubitemid 34211670)
80. GD Brown: Dectin-1: a signalling non-TLR patternrecognition receptor. Nat Rev Immunol 6, 33-43 (2006) (Pubitemid 43279751)
81. BN Gantner, RM Simmons, SJ Canavera, S Akira and DM Underhill: Collaborative induction of inflammatory responses by dectin-1 and Toll-like receptor 2. J Exp Med 197, 1107-1117 (2003) (Pubitemid 36570066)
82. BN Gantner, RM Simmons and DM Underhill: Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24, 1277-1286 (2005) (Pubitemid 40516610)
83. SE Heinsbroek, GD Brown and S Gordon: Dectin-1 escape by fungal dimorphism. Trends Immunol 26, 352-354 (2005) (Pubitemid 40835839)
84. RT Wheeler, D Kombe, SD Agarwala and GR Fink: Dynamic, morphotype-specific Candida albicans beta-glucan exposure during infection and drug treatment. PLoS Pathog 4, e1000227 (2008)
85. W Huang, L Na, PL Fidel and P Schwarzenberger: Requirement of interleukin-17A for systemic anti-Candida albicans host defense in mice. J Infect Dis 190, 624-631 (2004) (Pubitemid 38982105)
86. NW Palm and R Medzhitov: Antifungal defense turns 17. Nat Immunol 8, 549-551 (2007) (Pubitemid 46785115)
87. EV Acosta-Rodriguez, L Rivino, J Geginat, D Jarrossay, M Gattorno, A Lanzavecchia, F Sallusto and G Napolitani: Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8, 639-646 (2007) (Pubitemid 46785128)
88. S LeibundGut-Landmann, O Gross, MJ Robinson, F Osorio, EC Slack, SV Tsoni, E Schweighoffer, V Tybulewicz, GD Brown, J Ruland and C Reis e Sousa: Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat Immunol 8, 630-638 (2007) (Pubitemid 46785127)
89. A De Luca, T Zelante, C D'Angelo, S Zagarella, F Fallarino, A Spreca, RG Iannitti, P Bonifazi, JC Renauld, F Bistoni, P Puccetti and L Romani: IL-22 defines a novel immune pathway of antifungal resistance. Mucosal Immunol 3, 361-373 (2010)
90. FL van de Veerdonk, BJ Kullberg, IC Verschueren, T Hendriks, JW van der Meer, LA Joosten and MG Netea: Differential effects of IL-17 pathway in disseminated candidiasis and zymosan-induced multiple organ failure. Shock 34, 407-411 (2010)
91. W Haas, P Pereira and S Tonegawa: Gamma/delta cells. Annu Rev Immunol 11, 637-685 (1993) (Pubitemid 23115020)
92. D Fenoglio, A Poggi, S Catellani, F Battaglia, A Ferrera, M Setti, G Murdaca and MR Zocchi: Vdelta1 T lymphocytes producing IFN-gamma and IL-17 are expanded in HIV-1-infected patients and respond to Candida albicans. Blood 113, 6611-6618 (2009)
93. J Jones-Carson, A Vazquez-Torres, HC van der Heyde, T Warner, RD Wagner and E Balish: Gamma delta T cell-induced nitric oxide production enhances resistance to mucosal candidiasis. Nat Med 1, 552-557 (1995)
94. J Jones-Carson, A Vazquez-Torres, T Warner and E Balish: Disparate requirement for T cells in resistance to mucosal and acute systemic candidiasis. Infect Immun 68, 2363-2365 (2000) (Pubitemid 30164879)
95. A Poggi, S Catellani, A Musso and MR Zocchi: Gammadelta T lymphocytes producing IFNgamma and IL-17 in response to Candida albicans or mycobacterial antigens: possible implications for acute and chronic inflammation. Curr Med Chem 16, 4743-4749 (2009)
96. MS Renna, CM Figueredo, MC. Rodriguez-Galan, PA Icely, JM Peralta Ramos, SG Correa and CE Sotomayor: Abrogation of spontaneous liver tolerance during immune response to Candida albicans: contribution of NKT and hepatic mononuclear cells. Int Immunol 24, 315-325 (2012)
97. NR Cohen, RV Tatituri, A Rivera, GF Watts, EY Kim, A Chiba, BB Fuchs, E Mylonakis, GS Besra, SM Levitz, M Brigl and MB Brenner: Innate recognition of cell wall beta-glucans drives invariant natural killer T cell responses against fungi. Cell Host Microbe 10, 437-450 (2011)
98. M Prlic and TM Hohl: iNKTs foil fungi. Cell Host Microbe 10, 421-422 (2011)
99. N Tarumoto, Y Kinjo, N Kitano, D Sasai, K Ueno, A Okawara, Y Izawa, M Shinozaki, H Watarai, M Taniguchi, H Takeyama, S Maesaki, K Shibuya and Y Miyazaki: Exacerbation of Invasive Candida albicans Infection by Commensal Bacteria or a Glycolipid Through IFN-gamma Produced in Part by iNKT Cells. J Infect Dis 209, 799-810 (2014)
100. RB Ashman, A Fulurija and JM Papadimitriou: Both CD4+ and CD8+ lymphocytes reduce the severity of tissue lesions in murine systemic cadidiasis, and CD4+ cells also demonstrate strain-specific immunopathological effects. Microbiology 145, 1631-1640 (1999) (Pubitemid 29352007)
101. M Wuthrich, HI Filutowicz, T Warner, GS Deepe, Jr. and BS Klein: Vaccine immunity to pathogenic fungi overcomes the requirement for CD4 help in exogenous antigen presentation to CD8+ T cells: implications for vaccine development in immune-deficient hosts. J Exp Med 197, 1405-1416 (2003) (Pubitemid 36682540)
102. E Balish, FA Vazquez-Torres, J Jones-Carson, RD Wagner and T Warner: Importance of beta2-microglobulin in murine resistance to mucosal and systemic candidiasis. Infect Immun 64, 5092-5097 (1996) (Pubitemid 26403966)
103. JA Winkelstein, MC Marino, RB Johnston, Jr., J Boyle, J Curnutte, JI Gallin, HL Malech, SM Holland, H Ochs, P Quie, R H. Buckley, CB Foster, SJ Chanock and H Dickler: Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine, 79, 155-169 (2000) (Pubitemid 30327530)
104. BH Segal, J Kwon-Chung, TJ Walsh, BS Klein, M Battiwalla, NG Almyroudis, SM Holland and L Romani: Immunotherapy for fungal infections. Clin Infect Dis 42, 507-515 (2006) (Pubitemid 43202523)
105. L Tramsen, O Beck, FR Schuster, KP Hunfeld, JP Latge, J Sarfati, F Roger, T Klingebiel, U Koehl and T Lehrnbecher: Generation and characterization of anti-Candida T cells as potential immunotherapy in patients with Candida infection after allogeneic hematopoietic stem-cell transplant. J Infect Dis 196, 485-492 (2007) (Pubitemid 47093900)
106. RG Iannitti, A Carvalho and L Romani: From memory to antifungal vaccine design. Trends Immunol 33, 467-474 (2012)
107. E Paulovicova, L Paulovicova, R Pilisiova, S Bystricky, DV Yashunsky, AA Karelin, YE Tsvetkov and NE Nifantiev: Synthetically prepared glycooligosaccharides mimicking Candida albicans cell wall glycan antigens - novel tools to study hostpathogen interactions. FEMS Yeast Res 13, 659-673 (2013)
108. SP Smeekens, A Ng, Kumar, MD Johnson, TS Plantinga, C van Diemen, P Arts, ET Verwiel, MS Gresnigt, K Fransen, S van Sommeren, M Oosting, SC Cheng, LA Joosten, A Hoischen, BJ Kullberg, WK Scott, JR Perfect, JW van der Meer, C Wijmenga, MG Netea and RJ Xavier: Functional genomics identifies type I interferon pathway as central for host defense against Candida albicans. Nat Commun 4, 1342 (2013)
109. C Bourgeois, O Majer, IE Frohner, I Lesiak-Markowicz, KS Hildering, W Glaser, S Stockinger, T Decker, S Akira, M Muller and K Kuchler: Conventional dendritic cells mount a type I IFN response against Candida spp. requiring novel phagosomal TLR7-mediated IFN-beta signaling. J Immunol 186, 3104-3112 (2011)
110. C del Fresno, D Soulat, S Roth, K Blazek, I Udalova, D Sancho, J Ruland and C Ardavin: Interferon-beta production via Dectin-1-Syk-IRF5 signaling in dendritic cells is crucial for immunity to C. albicans. Immunity 38, 1176-1186 (2013)